Oral immunotherapy for allergy treatment may be safe for infants under 12 months of age

Researchers from the University of British Columbia (Canada) provide real-world evidence for the usefulness of oral immunotherapy in treating peanut allergies in infants. The study, published in Journal of Allergy and Clinical Immunology: In Practice, found that not only is oral immunotherapy effective against peanut allergies, but it is also even safer for infants younger than 12 months than it is for toddlers and older pre-schoolers. This builds on previous work from the researchers in 2019 that confirmed that pre-schoolers could overcome peanut allergies with oral immunotherapy treatment. Oral immunotherapy is a treatment in which the individual consumes small amounts...